The Global Fund allocates funding to countries to support HIV, TB and malaria programs and to build resilient and sustainable systems for health. These allocations are made every three years at the beginning of a new funding period.
The total amount available for allocations to countries depends on the funding raised during the corresponding three-year Replenishment cycle.
Allocations to individual countries are calculated using a formula that is predominantly based on each country’s disease burden and economic capacity. They are refined to account for important contextual factors through a transparent and accountable qualitative adjustment process.
The Global Fund refined the allocation methodology for 2020-2022 to better deliver on the objectives of the Global Fund Strategy and to further increase the impact of country programs. The methodology also builds on lessons from the previous allocation.
Our 2020-2022 funding cycle webinar series includes a session detailing allocations. Visit iLearn
The 2020-2022 methodology drives funding to higher burden, lower income countries, specifically accounting for HIV epidemics among key and vulnerable populations, the threat of multidrug-resistant TB, and for the risk of malaria resurgence, while providing sustainable and paced reductions where funding is decreasing.
In addition to country allocations, US$890 million is available for catalytic investments for 2020-2022. See our Catalytic Investments page for more information.